deaths (OS)

mML - L1 - all population metastatic/adv melanoma (mML) mML - 1st line (L1) mML - L1 - all population

versus Standard of Care (SoC)
tremelimumab vs. Standard of Care (SoC) 1 certainty unassessable-11%